ESC 365 - Low cardiovascular event rates in patients treated with CAR T-cells: real-world outcomes from two independent cohorts

ESC2025 Premium Access

Low cardiovascular event rates in patients treated with CAR T-cells: real-world outcomes from two independent cohorts

Session: Special populations in cardio-oncology

Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer

Speaker: Mr J. Voran (Kiel, DE)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Mr Jakob Voran

University Medical Center of Schleswig-Holstein, Kiel (Germany)

1 presentation

0 follower

8 more presentations in this session

Dysfunctional high-density lipoproteins in breast cancer patients and tumor-bearing mice treated with chemotherapy

Speaker: Professor S. Lecour (Cape Town, ZA)

Valvular heart disease in Cancer patiEntS - prevAlence, Relevance, and therapeutic management - preliminary results from the CESAR study

Speaker: Doctor L. Hauptmann (Vienna, AT)

Novel biomarker-based machine learning model in personalized cardiotoxicity prediction.

Speaker: Ms I. Liu (Austin, US)

The incidence and risk factors for early onset atrial fibrillation in allogeneic and autologous hematopoietic stem cell transplant patients

Speaker: Ms L. Cai (Duarte, US)

Clinical and echocardiographic characteristics of neuroendocrine tumours and carcinoid heart disease: insights from a contemporary canadian cohort study

Speaker: Mr J. Yoon (Vancouver, CA)

Access the full session

Special populations in cardio-oncology

Speakers: Mr J. Voran, Professor S. Lecour, Doctor L. Hauptmann, Ms I. Liu, Ms L. Cai...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources